ProKidney (PROK) Institutional Ownership $1.55 -0.05 (-3.13%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for ProKidney (NASDAQ:PROK)CurrentInstitutional OwnershipPercentage51.59%Number ofInstitutional Buyers(last 12 months)11TotalInstitutional Inflows(last 12 months)$1.05MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$2.08M Get PROK Insider Trade Alerts Want to know when executives and insiders are buying or selling ProKidney stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PROK Institutional Buying and Selling by Quarter Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here ProKidney Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/21/2024 Castleview Partners LLC32,921$63K0.0%N/A0.014% 8/15/2024Susquehanna Fundamental Investments LLC42,990$106K0.0%N/A0.019% 8/15/2024The Manufacturers Life Insurance Company24,566$60K0.0%N/A0.011% 8/15/2024AQR Capital Management LLC20,518$50K0.0%N/A0.009% 8/14/2024Marshall Wace LLP50,242$124K0.0%N/A0.022% 8/8/2024Federated Hermes Inc.23,303$57K0.0%-79.4%0.010% Get the Latest News and Ratings for PROK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProKidney and its competitors with MarketBeat's FREE daily newsletter. 8/1/2024Rhumbline Advisers76,190$187K0.0%+8.8%0.033% 7/26/2024Bank of New York Mellon Corp179,236$441K0.0%+44.6%0.078% 5/10/2024Vanguard Group Inc.1,813,079$2.97M0.0%-37.5%0.791% 4/24/2024 Zullo Investment Group Inc.19,420$32K0.0%N/A0.008% 2/7/2024Jump Financial LLC21,677$39K0.0%-54.0%0.009% 1/31/2024Federated Hermes Inc.113,286$202K0.0%+10,984.7%0.048% 1/12/2024 SG Americas Securities LLC46,829$83K0.0%+174.2%0.020% 11/7/2023 New York State Common Retirement Fund17,274$79K0.0%-30.1%0.007% 11/7/2023Jump Financial LLC47,100$216K0.0%N/A0.020% 10/27/2023 Social Capital Group LLC11,573,000$53.00M89.0%-12.8%4.922% 10/24/2023Bank of New York Mellon Corp127,956$586K0.0%-21.9%0.054% 10/13/2023 SG Americas Securities LLC17,080$78K0.0%N/A0.007% 8/10/2023Letko Brosseau & Associates Inc.15,900$178K0.0%N/A0.007% 8/10/2023Metropolitan Life Insurance Co NY3,429$38K0.0%N/A0.001% 8/4/2023American International Group Inc.29,698$332K0.0%N/A0.013% 8/3/2023Bank of New York Mellon Corp163,811$1.83M0.0%N/A0.070% 7/31/2023Strs Ohio12,800$143K0.0%N/A0.005% 7/19/2023 Salem Investment Counselors Inc.3,000$34K0.0%+547.9%0.001% 2/13/2023 Social Capital Group LLC13,273,000$91.05M77.7%N/A51.767% 2/8/2023Swiss National Bank74,301$510K0.0%N/A0.290% 1/24/2023Brown University1,000,000$6.86M2.9%N/A3.900% 11/15/2022Bleichroeder LP2,000,000$18.02M3.8%N/A7.800% 11/14/2022Verition Fund Management LLC14,603$132K0.0%N/A0.057% 11/14/2022Moore Capital Management LP26,500$239K0.0%N/A0.103% (Data available from 1/1/2016 forward) PROK Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PROK shares? During the previous two years, 24 institutional investors and hedge funds held shares of ProKidney. The most heavily invested institutionals were Social Capital Group LLC ($53.00M), Bleichroeder LP ($18.02M), Brown University ($6.86M), Vanguard Group Inc. ($2.97M), Swiss National Bank ($510K), Bank of New York Mellon Corp ($441K), and American International Group Inc. ($332K).Learn more on PROK's institutional investors. What percentage of ProKidney stock is owned by institutional investors? 51.59% of ProKidney stock is owned by institutional investors. Learn more on PROK's institutional investor holdings. Which institutional investors have been buying ProKidney stock? Of the 22 institutional investors that purchased ProKidney stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Social Capital Group LLC ($13.27M), Bleichroeder LP ($2M), Brown University ($1M), Bank of New York Mellon Corp ($219.08K), Federated Hermes Inc. ($112.26K), Swiss National Bank ($74.30K), and Marshall Wace LLP ($50.24K). How much institutional buying is happening at ProKidney? Institutional investors have bought a total of 17,074,876 shares in the last 24 months. This purchase volume represents approximately $120.50M in transactions. Which ProKidney major shareholders have been selling company stock? The following institutional investors have sold ProKidney stock in the last 24 months: Social Capital Group LLC ($1.70M), Vanguard Group Inc. ($1.09M), Federated Hermes Inc. ($89.98K), Bank of New York Mellon Corp ($35.86K), Jump Financial LLC ($25.42K), and New York State Common Retirement Fund ($7.43K). How much institutional selling is happening at ProKidney? Institutional investors have sold a total of 2,944,652 shares in the last 24 months. This volume of shares sold represents approximately $10.03M in transactions. Related Companies AKLI Major Shareholders CNTA Major Shareholders GLPG Major Shareholders NRIX Major Shareholders SYRE Major Shareholders WVE Major Shareholders OCUL Major Shareholders SNDX Major Shareholders NAMS Major Shareholders KNSA Major Shareholders This page (NASDAQ:PROK) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProKidney Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProKidney With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
